Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Delays Enforcement For Class III Reprocessed SUDs With Pending PMAs

This article was originally published in The Gray Sheet

Executive Summary

FDA's reuse policy does not follow precedents set by previous calls for PMAs from original equipment manufacturers, SterilMed argued in a partially successful petition to suspend enforcement actions on Class III device reprocessors.

You may also be interested in...



Single-Use Device Reprocessor 510(k) Requirements Delayed Until Summer

FDA announced at the eleventh hour that it will extend by six months the deadline for active enforcement of premarket requirements for reprocessors of Class II single-use devices, giving the firms a Valentine's Day reprieve

Single-Use Device Reprocessor 510(k) Requirements Delayed Until Summer

FDA announced at the eleventh hour that it will extend by six months the deadline for active enforcement of premarket requirements for reprocessors of Class II single-use devices, giving the firms a Valentine's Day reprieve

OEM Trademarks On Reprocessed Single-Use Devices Acceptable, FDA Says

FDA regulations do not require reprocessors to remove original equipment manufacturer (OEM) trademarks and references to OEMs from reprocessed devices, but the reprocessor must make clear that it, not the OEM, is the manufacturer of the reprocessed single-use device, FDA states in its Sept. 17 denial of a petition from the Association of Disposable Device Manufacturers.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015299

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel